Alan Kennedy

3.3k total citations
36 papers, 1.3k citations indexed

About

Alan Kennedy is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Alan Kennedy has authored 36 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Immunology, 11 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Alan Kennedy's work include T-cell and B-cell Immunology (18 papers), Immune Cell Function and Interaction (16 papers) and Immunotherapy and Immune Responses (7 papers). Alan Kennedy is often cited by papers focused on T-cell and B-cell Immunology (18 papers), Immune Cell Function and Interaction (16 papers) and Immunotherapy and Immune Responses (7 papers). Alan Kennedy collaborates with scholars based in United Kingdom, United States and Canada. Alan Kennedy's co-authors include Adam P. Cribbs, Fionula M. Brennan, Bernard Gregory, Tawfiq Khansur, Parisa Amjadi, Patricia Green, David M. Sansom, Henry Penn, Jordan E. Read and Richard Williams and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Alan Kennedy

35 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan Kennedy United Kingdom 21 590 367 362 193 180 36 1.3k
Mercedes Zubiaur Spain 24 827 1.4× 233 0.6× 583 1.6× 161 0.8× 64 0.4× 50 1.7k
Daniel J. Shaffer United States 15 1.1k 1.9× 204 0.6× 522 1.4× 96 0.5× 202 1.1× 27 2.1k
Richard Huijbens Netherlands 18 1.1k 1.9× 338 0.9× 630 1.7× 140 0.7× 121 0.7× 21 2.0k
Tong‐Yuan Yang United States 15 479 0.8× 516 1.4× 397 1.1× 188 1.0× 188 1.0× 39 1.2k
H. E. Ramsey United States 17 1.2k 2.0× 376 1.0× 678 1.9× 113 0.6× 146 0.8× 32 2.2k
Margaret Morris United States 14 967 1.6× 131 0.4× 329 0.9× 151 0.8× 268 1.5× 22 1.5k
Teresa L. Born United States 13 661 1.1× 240 0.7× 718 2.0× 119 0.6× 84 0.5× 19 1.2k
Andrew G. Levine United States 7 1.4k 2.4× 421 1.1× 307 0.8× 101 0.5× 152 0.8× 9 2.0k
Zining Wu United States 22 320 0.5× 172 0.5× 735 2.0× 162 0.8× 111 0.6× 60 1.4k
Ko Okumura Japan 19 995 1.7× 198 0.5× 501 1.4× 118 0.6× 80 0.4× 48 1.7k

Countries citing papers authored by Alan Kennedy

Since Specialization
Citations

This map shows the geographic impact of Alan Kennedy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Kennedy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Kennedy more than expected).

Fields of papers citing papers by Alan Kennedy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Kennedy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Kennedy. The network helps show where Alan Kennedy may publish in the future.

Co-authorship network of co-authors of Alan Kennedy

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Kennedy. A scholar is included among the top collaborators of Alan Kennedy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Kennedy. Alan Kennedy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kennedy, Alan, Hung‐Chang Chen, Erin Waters, et al.. (2024). Rigid, bivalent CTLA-4 binding to CD80 is required to disrupt the cis CD80/PD-L1 interaction. Cell Reports. 43(9). 114768–114768. 5 indexed citations
2.
Kennedy, Alan, Claudia Hinze, Erin Waters, et al.. (2023). The CTLA ‐4 immune checkpoint protein regulates PD‐L1 : PD ‐1 interaction via transendocytosis of its ligand CD80. The EMBO Journal. 42(5). e111556–e111556. 14 indexed citations
3.
Fox, Thomas A., Lina Petersone, Erin Waters, et al.. (2022). Therapeutic gene editing of T cells to correct CTLA-4 insufficiency. Science Translational Medicine. 14(668). eabn5811–eabn5811. 21 indexed citations
4.
Williams, Cayman, et al.. (2022). Impact of CTLA-4 checkpoint antibodies on ligand binding and Transendocytosis. Frontiers in Immunology. 13. 871802–871802. 5 indexed citations
5.
Soskic, Blagoje, Louisa Jeffery, Alan Kennedy, et al.. (2021). CD80 on Human T Cells Is Associated With FoxP3 Expression and Supports Treg Homeostasis. Frontiers in Immunology. 11. 577655–577655. 27 indexed citations
6.
Janman, Daniel, Claudia Hinze, Alan Kennedy, et al.. (2021). Regulation of CTLA‐4 recycling by LRBA and Rab11. Immunology. 164(1). 106–119. 26 indexed citations
7.
Halliday, Neil, Cayman Williams, Alan Kennedy, et al.. (2020). CD86 Is a Selective CD28 Ligand Supporting FoxP3+ Regulatory T Cell Homeostasis in the Presence of High Levels of CTLA-4. Frontiers in Immunology. 11. 600000–600000. 58 indexed citations
8.
Glinos, Dafni A., Blagoje Soskic, Cayman Williams, et al.. (2020). Genomic profiling of T-cell activation suggests increased sensitivity of memory T cells to CD28 costimulation. Genes and Immunity. 21(6-8). 390–408. 24 indexed citations
9.
Hou, Tie Zheng, Nisha Verma, Jennifer Wanders, et al.. (2017). Identifying functional defects in patients with immune dysregulation due to LRBA and CTLA-4 mutations. Blood. 129(11). 1458–1468. 71 indexed citations
10.
Kennedy, Alan & Adam P. Cribbs. (2016). Production and Concentration of Lentivirus for Transduction of Primary Human T Cells. Methods in molecular biology. 1448. 85–93. 10 indexed citations
11.
Kennedy, Alan, Paul Spiers, Vivion Crowley, Emlyn Williams, & Fiona E. Lithander. (2015). Postprandial adiponectin and gelatinase response to a high-fat versus an isoenergetic low-fat meal in lean, healthy men. Nutrition. 31(6). 863–870. 12 indexed citations
12.
Cribbs, Adam P., Alan Kennedy, Henry Penn, et al.. (2014). Treg Cell Function in Rheumatoid Arthritis Is Compromised by CTLA‐4 Promoter Methylation Resulting in a Failure to Activate the Indoleamine 2,3‐Dioxygenase Pathway. Arthritis & Rheumatology. 66(9). 2344–2354. 114 indexed citations
13.
Kennedy, Alan, Andreea Petrasca, Derek G. Doherty, Martina Hennessy, & Paul Spiers. (2013). HIV-1 Tat clade-specific cytokine induction in monocytes/macrophages is not evidenced in total or Vγ9Vδ2 T lymphocytes. AIDS. 28(1). 131–133. 1 indexed citations
14.
Cribbs, Adam P., Alan Kennedy, Bernard Gregory, & Fionula M. Brennan. (2013). Simplified production and concentration of lentiviral vectors to achieve high transduction in primary human T cells. BMC Biotechnology. 13(1). 98–98. 93 indexed citations
15.
Kennedy, Alan, Martina Hennessy, Colm Bergin, et al.. (2011). Ribavirin and Interferon Alter Mmp-9 Abundance In Vitro and in HIV–HCV-Coinfected Patients. Antiviral Therapy. 16(8). 1237–1247. 9 indexed citations
16.
17.
Esseghir, Selma, JS Reis‐Filho, Alan Kennedy, et al.. (2006). Identification of transmembrane proteins as potential prognostic markers and therapeutic targets in breast cancer by a screen for signal sequence encoding transcripts. The Journal of Pathology. 210(4). 420–430. 64 indexed citations
18.
Khansur, Tawfiq & Alan Kennedy. (1991). Cisplatin and 5-fluorouracil for advanced locoregional and metastatic squamous cell carcinoma of the skin. Cancer. 67(8). 2030–2032. 87 indexed citations
19.
Khansur, Tawfiq & Alan Kennedy. (1991). Case Report: Cisplatin-lnduced Hemolytic Uremic Syndrome. The American Journal of the Medical Sciences. 301(6). 390–392. 11 indexed citations
20.
Kennedy, Alan, Barbara R. Williams, Edward F. Meydrech, & Martin H. Steinberg. (1988). Regional and temporal variation in oscillatory blood flow in sickle cell disease. American Journal of Hematology. 28(2). 92–94. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mercedes Zubiaur Breakdown of academic impact, for papers by Daniel J. Shaffer Breakdown of academic impact, for papers by Richard Huijbens Breakdown of academic impact, for papers by Tong‐Yuan Yang Breakdown of academic impact, for papers by H. E. Ramsey Breakdown of academic impact, for papers by Margaret Morris Breakdown of academic impact, for papers by Teresa L. Born Breakdown of academic impact, for papers by Andrew G. Levine Breakdown of academic impact, for papers by Zining Wu Breakdown of academic impact, for papers by Ko Okumura
Rankless by CCL
2026